Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0
|
作者：
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构：
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I：
10.2165/00003495-200666002-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：29 / 31
页数：2
相关论文
共 50 条
  • [21] Improvement in social functioning in kidney transplant patients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®):: Three case studies
    Shah, Tariq
    DRUGS, 2006, 66 : 15 - 17
  • [22] Mouth ulcers induced by enteric-coated mycophenolate sodium (Myfortic®)
    Miquel, O.
    Chaby, G.
    Andrejak, M.
    Brenet-Dufour, V.
    Makdassi, R.
    Denoeux, J. -P.
    Lok, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2007, 134 (11): : 855 - 857
  • [23] Enteric-coated mycophenolate sodium: Safe conversion from mycophenolate mofetil in maintenance renal transplant recipients
    Budde, K
    Glander, P
    Diekmann, F
    Dragun, D
    Waiser, J
    Fritsche, L
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 524S - 527S
  • [24] Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
    Liao, Yu-Wan
    Hung, Wei-Ting
    Chen, Yi-Ming
    Hsu, Chiann-Yi
    Lin, Ching-Heng
    Hsieh, Tsu-Yi
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lin, Ching-Tsai
    Lai, Kuo-Lung
    Tang, Kuo-Tung
    Tseng, Chih-Wei
    Chen, Yi-Hsing
    Huang, Wen-Nan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E633 - E637
  • [25] Benefits of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in pediatric renal transplant patients with stable graft function
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Halusch
    PEDIATRIC TRANSPLANTATION, 2009, 13 (02) : 188 - 193
  • [26] Enteric-coated mycophenolate sodium - Tolerability profile compared with mycophenolate mofetil
    Behrend, M
    Braun, F
    DRUGS, 2005, 65 (08) : 1037 - 1050
  • [27] Improvement in Social Functioning in Kidney Transplant Patients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®): Three Case Studies
    Tariq Shah
    Drugs, 2006, 66 (Suppl 2) : 15 - 17
  • [28] Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: Conversion to enteric-coated mycophenolate sodium
    Calvo, N.
    Sanchez-Fructuoso, A. I.
    Conesa, J.
    Moreno, A.
    Barrientos, A.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2396 - 2397
  • [29] Safety conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in children with stable renal transplant.
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Hallush
    Olandoski, Karen Previch
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 54 - 54
  • [30] Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
    Jones, Rachel B.
    Walsh, Michael
    Chaudhry, Afzal N.
    Smith, Kenneth G. C.
    Jayne, David R. W.
    CLINICAL KIDNEY JOURNAL, 2014, 7 (06): : 562 - 568
12345